Bilal Arif - 10 Mar 2025 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role: Chief Tech Ops Officer
Signature: /s/ Cristin Rothfuss, as Attorney-in-Fact for Bilal Arif
Issuer symbol: SRPT
Transactions as of: 10 Mar 2025
Net transactions value: -$52,368
Form type: 4
Filing time: 11 Mar 2025, 20:00:08 UTC
Previous filing: 10 Mar 2025
Next filing: 06 Aug 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SRPT	Common Stock	Tax liability	$52,368	-523	-2.1%	$100.13	24,224	10 Mar 2025	Direct	F1
transaction	SRPT	Common Stock	Award		+8,276	+34%		32,500	10 Mar 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SRPT	Stock Options (right to buy)	Award	$0	+16,644		$0.000000	16,644	10 Mar 2025	Common Stock	16,644	$99.69	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022.
F2	The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date.
F3	Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter.